Published on September 25, 2024–Updated on December 10, 2024
AC. Ludzki, M. Hansen, D. Zareifi, J. Jalkanen, Z. Huang, M. Omar-Hmeadi, G. Renzi, F. Klingelhuber, S. Boland, YA. Ambaw, N. Wang, A. Damdimopoulos, J. Liu, T. Jernberg, P. Petrus, P. Arner, N. Krahmer, R. Fan, E. Treuter, H. Gao, M. Rydén, N. Mejhert (2024)
Abstract
Defects in adipocyte lipolysis drive multiple aspects of cardiometabolic disease, but the transcriptional framework controlling this process has not been established. To address this, we performed a targeted perturbation screen in primary human adipocytes. Our analyses identified 37 transcriptional regulators of lipid mobilization, which we classified as (i) transcription factors, (ii) histone chaperones, and (iii) mRNA processing proteins. On the basis of its strong relationship with multiple readouts of lipolysis in patient samples, we performed mechanistic studies on one hit, ZNF189, which encodes the zinc finger protein 189. Using mass spectrometry and chromatin profiling techniques, we show that ZNF189 interacts with the tripartite motif family member TRIM28 and represses the transcription of an adipocyte-specific isoform of phosphodiesterase 1B (PDE1B2). The regulation of lipid mobilization by ZNF189 requires PDE1B2, and the overexpression of PDE1B2 is sufficient to attenuate hormone-stimulated lipolysis. Thus, our work identifies the ZNF189-PDE1B2 axis as a determinant of human adipocyte lipolysis and highlights a link between chromatin architecture and lipid mobilization.
